Thrombin generation is increased in patients with Clostridium difficile colitis - a pilot study

Romeo G Mihăilă1,2, Crina Cătană3, Ariela L Olteanu4

  • 1a Faculty of Medicine , "Lucian Blaga" University of Sibiu , Sibiu , Romania.

Insights

Clostridium difficile (CD) colitis patients show increased thrombin generation, indicating a higher risk of blood clots. This finding suggests a need for monitoring and potential thromboprophylaxis in these individuals.

Area of Science:

  • Coagulation and Thrombosis
  • Infectious Diseases
  • Gastroenterology

Background:

  • Limited data exists on thrombotic risk in Clostridium difficile (CD) colitis.
  • CD colitis is a globally prevalent condition.
  • Evaluating coagulation is crucial for understanding patient risk.

Purpose of the Study:

  • To investigate thrombin generation in patients with CD colitis.
  • To assess the coagulation status in CD colitis patients.
  • To identify potential thrombotic risks associated with CD colitis.

Main Methods:

  • Prospective observational study over 15 months.
  • Inclusion of hospitalized patients diagnosed with CD colitis.
  • Thrombin generation analysis using a Ceveron® alpha analyzer in platelet-poor plasma.
  • Comparison with healthy volunteer control subjects.

Main Results:

  • Thirty-three CD colitis patients and 51 controls were analyzed.
  • Significantly higher mean velocity index and peak thrombin levels observed in patients compared to controls (p=0.010, p=0.0395).
  • Thrombin generation patterns suggest potential thrombotic risk in CD colitis patients without septic shock.
  • Mean velocity index correlated with Charlson age-comorbidity index for estimated mortality risk.

Conclusions:

  • Elevated thrombin generation in CD colitis patients suggests an increased thromboembolic risk.
  • Thrombin generation patterns can identify patients at higher risk.
  • These patients may benefit from thromboprophylaxis strategies and closer monitoring.

Related Concept Videos

Pilot and Numeric Relaying01:21

Pilot and Numeric Relaying

Pilot relaying is a type of differential protection used in power systems. It compares electrical quantities at the terminals of equipment via a communication channel instead of direct relay interconnection. This method is essential for transmission lines where the terminals are far apart, typically up to 80 km for lines with 69 to 115 kV ratings. Four types of communication channels are used for pilot relaying:
487
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
6.5K
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
1.1K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
146
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
956
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
483